Free Trial

Dilation Capital Management LP Takes $1.93 Million Position in Oracle Co. (NYSE:ORCL)

Oracle logo with Computer and Technology background

Dilation Capital Management LP acquired a new position in shares of Oracle Co. (NYSE:ORCL - Free Report) in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund acquired 11,600 shares of the enterprise software provider's stock, valued at approximately $1,933,000. Oracle accounts for about 1.8% of Dilation Capital Management LP's holdings, making the stock its 17th biggest holding.

A number of other hedge funds have also bought and sold shares of ORCL. R Squared Ltd bought a new stake in shares of Oracle during the fourth quarter worth $25,000. Winch Advisory Services LLC increased its stake in Oracle by 89.7% in the 4th quarter. Winch Advisory Services LLC now owns 184 shares of the enterprise software provider's stock worth $31,000 after buying an additional 87 shares during the period. Hurley Capital LLC bought a new stake in Oracle during the 4th quarter valued at about $33,000. Synergy Investment Management LLC purchased a new stake in Oracle in the 4th quarter valued at about $34,000. Finally, TFC Financial Management Inc. grew its stake in Oracle by 129.0% in the 4th quarter. TFC Financial Management Inc. now owns 213 shares of the enterprise software provider's stock worth $35,000 after acquiring an additional 120 shares in the last quarter. Institutional investors own 42.44% of the company's stock.

Oracle Stock Performance

Shares of ORCL traded up $4.19 during trading hours on Wednesday, reaching $131.43. 9,520,592 shares of the company traded hands, compared to its average volume of 9,368,622. The stock has a market capitalization of $367.60 billion, a P/E ratio of 32.13, a P/E/G ratio of 3.46 and a beta of 1.22. The company has a quick ratio of 0.81, a current ratio of 0.81 and a debt-to-equity ratio of 5.65. The business has a fifty day moving average price of $148.08 and a 200-day moving average price of $165.49. Oracle Co. has a 12-month low of $112.78 and a 12-month high of $198.31.

Oracle (NYSE:ORCL - Get Free Report) last announced its quarterly earnings data on Monday, March 10th. The enterprise software provider reported $1.47 earnings per share for the quarter, missing analysts' consensus estimates of $1.49 by ($0.02). Oracle had a net margin of 21.16% and a return on equity of 133.25%. The firm had revenue of $14.13 billion during the quarter, compared to analyst estimates of $14.40 billion. During the same period in the prior year, the company posted $1.41 earnings per share. The firm's revenue for the quarter was up 6.4% on a year-over-year basis. Equities analysts anticipate that Oracle Co. will post 5 EPS for the current fiscal year.

Oracle Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, April 23rd. Shareholders of record on Thursday, April 10th will be paid a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a yield of 1.52%. This is a boost from Oracle's previous quarterly dividend of $0.40. The ex-dividend date is Thursday, April 10th. Oracle's payout ratio is presently 46.95%.

Insider Activity

In related news, CEO Safra Catz sold 345,174 shares of Oracle stock in a transaction that occurred on Friday, January 24th. The stock was sold at an average price of $185.56, for a total transaction of $64,050,487.44. Following the completion of the transaction, the chief executive officer now directly owns 1,118,592 shares in the company, valued at approximately $207,565,931.52. This trade represents a 23.58 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Naomi O. Seligman sold 2,000 shares of the company's stock in a transaction that occurred on Wednesday, April 2nd. The stock was sold at an average price of $145.81, for a total value of $291,620.00. Following the completion of the sale, the director now owns 34,630 shares in the company, valued at approximately $5,049,400.30. This represents a 5.46 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 352,174 shares of company stock valued at $64,990,957 in the last ninety days. Insiders own 42.20% of the company's stock.

Wall Street Analyst Weigh In

ORCL has been the subject of a number of research reports. JPMorgan Chase & Co. lowered their price target on Oracle from $140.00 to $135.00 and set a "neutral" rating for the company in a report on Tuesday, March 11th. Citigroup lowered their target price on Oracle from $194.00 to $160.00 and set a "neutral" rating for the company in a report on Wednesday, March 12th. Bank of America dropped their price target on Oracle from $195.00 to $175.00 and set a "neutral" rating on the stock in a research report on Tuesday, March 11th. Mizuho decreased their price objective on Oracle from $210.00 to $180.00 and set an "outperform" rating for the company in a report on Tuesday, April 15th. Finally, Morgan Stanley dropped their target price on shares of Oracle from $170.00 to $160.00 and set an "equal weight" rating on the stock in a report on Wednesday, April 16th. Fourteen investment analysts have rated the stock with a hold rating, fifteen have assigned a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of "Moderate Buy" and an average target price of $174.42.

View Our Latest Analysis on ORCL

Oracle Profile

(Free Report)

Oracle Corporation offers products and services that address enterprise information technology environments worldwide. Its Oracle cloud software as a service offering include various cloud software applications, including Oracle Fusion cloud enterprise resource planning (ERP), Oracle Fusion cloud enterprise performance management, Oracle Fusion cloud supply chain and manufacturing management, Oracle Fusion cloud human capital management, Oracle Cerner healthcare, Oracle Advertising, and NetSuite applications suite, as well as Oracle Fusion Sales, Service, and Marketing.

Featured Stories

Institutional Ownership by Quarter for Oracle (NYSE:ORCL)

Should You Invest $1,000 in Oracle Right Now?

Before you consider Oracle, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Oracle wasn't on the list.

While Oracle currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Related Videos

Google’s $32B Move: 3 Cybersecurity Stocks to Watch
3 AI Stocks to Watch After NVIDIA’s Dip
3 AI Bargain Stocks to BUY NOW After the DeepSeek Crash

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines